Profile data is unavailable for this security.
About the company
Bide Pharmatech Co Ltd is a China-based company principally engaged in the research, development, production, and sales of drug molecular building blocks. The Company is mainly engaged in the research, development, production, and sales of drug molecular building blocks and scientific reagents, serving key stages of new drug research and development. The Company's main products are pharmaceutical molecular building blocks and scientific reagents. The Company's products are mainly applied in drug target discovery, lead compound synthesis and screening, lead compound discovery, synthesis and optimization, and other stages of new drug research and development. The Company mainly operates in the domestic and overseas markets.
- Revenue in CNY (TTM)1.27bn
- Net income in CNY153.31m
- Incorporated2007
- Employees738.00
- LocationBide Pharmatech Co LtdShanghai 200433ChinaCHN
- Phone+86 2 161601560
- Fax+86 2 161629029
- Websitehttps://www.bidepharm.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Xinjiang Bai Hua Cun Pharma Tech Co Ltd | 393.73m | 50.20m | 3.57bn | 731.00 | 71.07 | 4.50 | -- | 9.07 | 0.1307 | 0.1307 | 1.02 | 2.06 | 0.3503 | 1.94 | 1.88 | 538,619.70 | 4.47 | -4.60 | 6.16 | -6.38 | 51.82 | 24.75 | 12.75 | -16.33 | 1.81 | -- | 0.00 | -- | 4.46 | 8.04 | 219.75 | 3.82 | -0.975 | -- |
| Qingdao Vland Biotech INC | 1.39bn | 83.57m | 3.96bn | 1.57k | 47.54 | 2.23 | -- | 2.85 | 0.329 | 0.329 | 5.50 | 7.01 | 0.4585 | 3.89 | 3.65 | -- | 3.76 | 4.84 | 6.11 | 6.94 | 44.19 | 45.52 | 8.20 | 9.54 | 0.877 | -- | 0.2648 | 32.35 | 10.16 | 9.30 | -22.39 | -4.23 | -2.71 | -6.89 |
| Hinova Pharmaceuticals Inc | 23.61m | -144.57m | 4.47bn | 173.00 | -- | 4.06 | -- | 189.15 | -1.46 | -1.46 | 0.2384 | 11.12 | 0.0171 | 2.37 | 5.59 | 136,467.70 | -10.45 | -26.09 | -11.68 | -29.74 | 95.50 | -- | -612.36 | -78,863.60 | 6.90 | -- | 0.0883 | -- | -- | -38.67 | 32.18 | -- | 139.77 | -- |
| Shanghai Aladdin Biochemical Tech Co Ltd | 599.98m | 83.95m | 5.28bn | 652.00 | 63.82 | 4.95 | -- | 8.79 | 0.2485 | 0.2485 | 1.78 | 3.21 | 0.2785 | 0.4218 | 4.55 | 920,216.30 | 5.04 | 7.81 | 6.90 | 8.60 | 62.21 | 60.61 | 18.09 | 24.95 | 1.53 | 9.15 | 0.3541 | 48.33 | 32.44 | 20.55 | 15.07 | 9.17 | 41.61 | -- |
| Hangzhou Alltest Biotech Co Ltd | 881.63m | 294.76m | 5.41bn | 969.00 | 18.33 | 1.39 | -- | 6.14 | 3.72 | 3.72 | 11.12 | 49.21 | 0.2098 | 2.38 | 6.39 | 909,839.10 | 7.02 | 19.18 | 7.57 | 21.66 | 55.00 | 57.79 | 33.47 | 38.82 | 8.34 | -- | 0.0093 | 35.14 | 14.83 | 29.13 | 67.50 | 30.99 | 71.01 | -- |
| Bide Pharmatech Co Ltd | 1.27bn | 153.31m | 5.43bn | 738.00 | 33.98 | 2.71 | -- | 4.27 | 1.76 | 1.76 | 14.49 | 22.03 | 0.5167 | 0.8804 | 5.25 | 1,720,520.00 | 6.24 | 7.02 | 7.52 | 8.29 | 43.30 | 42.16 | 12.07 | 13.13 | 2.78 | -- | 0.1055 | 48.73 | 0.9298 | 34.69 | 7.17 | -- | 80.65 | -- |
| Shouyao Holdings Co Ltd | 2.14m | -206.73m | 5.78bn | 178.00 | -- | 8.83 | -- | 2,697.32 | -1.39 | -1.39 | 0.0144 | 4.40 | 0.0025 | 0.0366 | 0.2625 | 12,033.88 | -23.67 | -32.53 | -27.20 | -36.25 | 95.74 | 99.43 | -9,651.03 | -3,370.01 | 6.42 | -- | 0.0044 | -- | -24.61 | -19.34 | -14.21 | -- | 49.71 | -- |
| Jiangsu Yahong Meditech Co Ltd | 279.02m | -362.17m | 6.84bn | 391.00 | -- | 3.86 | -- | 24.52 | -0.642 | -0.642 | 0.4933 | 3.10 | 0.125 | 11.16 | 4.19 | 713,603.90 | -16.84 | -14.30 | -19.15 | -15.01 | 72.22 | 73.78 | -134.65 | -703.80 | 4.96 | -- | 0.1545 | -- | 1,365.55 | -- | 4.09 | -- | 50.48 | -- |
| GemPharmatech Co Ltd | 752.70m | 121.51m | 6.98bn | 1.58k | 56.61 | 3.17 | -- | 9.27 | 0.3007 | 0.3007 | 1.86 | 5.37 | 0.2807 | 4.51 | 1.88 | 476,993.40 | 4.53 | 7.69 | 5.42 | 8.96 | 61.84 | 68.17 | 16.14 | 25.58 | 3.17 | -- | 0.1295 | 21.94 | 10.39 | 28.94 | -30.89 | 25.88 | 20.02 | -- |
| Beijing Sun-Novo Pharma Research Co Ltd | 1.02bn | 133.01m | 7.46bn | 1.36k | 54.87 | 6.42 | -- | 7.34 | 1.21 | 1.21 | 9.23 | 10.38 | 0.4745 | 35.48 | 1.28 | 653,956.40 | 6.04 | 11.39 | 10.49 | 18.82 | 48.60 | 53.31 | 12.72 | 19.66 | 1.78 | 9.97 | 0.3355 | 11.29 | 15.70 | 35.80 | -3.98 | 30.21 | 3.50 | -- |
Data as of Feb 13 2026. Currency figures normalised to Bide Pharmatech Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
40.46%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Zhong Ou Asset Management Co., Ltdas of 30 Sep 2025 | 6.48m | 17.30% |
| E Fund Management Co., Ltd.as of 30 Sep 2025 | 2.25m | 6.01% |
| ICBC UBS Asset Management Co. Ltd.as of 30 Jun 2025 | 1.36m | 3.63% |
| ABC-CA Fund Management Co., Ltd.as of 30 Jun 2025 | 1.22m | 3.25% |
| GF Fund Management Co., Ltd.as of 30 Jun 2025 | 922.46k | 2.47% |
| China Merchants Fund Management Co., Ltd.as of 30 Jun 2025 | 835.20k | 2.23% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2025 | 581.75k | 1.56% |
| Chang Xin Asset Management Co., Ltd.as of 30 Jun 2025 | 560.10k | 1.50% |
| Bank of Communications Schroder Fund Management Co., Ltd.as of 30 Sep 2025 | 475.11k | 1.27% |
| HuaAn Fund Management Co., Ltd.as of 30 Jun 2025 | 466.33k | 1.25% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
